HIV/AIDS Therapy
Lamivudine has modest effect against M184V mutants
Published in AIDS Weekly, March 24th, 2003
The M184V mutation in HIV reverse transcriptase "is associated with high-level resistance to both (-)2',3'-dideoxy-3'-thiacytidine (3TC) and (-)2',3'-dideoxy-5-fluoro-3'-thiacytidine as well as low-level resistance to 2',3'-dideoxyinosine, 2',3'-dideoxycytidine, and abacavir," explained researchers in Canada. "This mutation is also associated with diminished HIV replicative fitness as well as several functional changes in enzyme activity, including diminutions in polymerase processivity, pyrophosphorylysis, and nucleotide primer unblocking."
"Despite the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-03-24)
More Articles from AIDS Weekly
- Cell Biology
Researchers identify protein that helps HIV penetrate cells - HIV/AIDS Pediatric
Peptide T bolus can normalize growth hormone secretion - Biotechnology
Dendritic cells pulsed with HIV TAT fusion protein induce antigen-specific CTLs - HIV/AIDS Progression
Low expression of inhibitory natural killer receptors seen on cytotoxic T cells - HIV/AIDS Therapy
HIV-based vector systems can be used to find novel antiviral agents - AIDS Policy
Private sector must do more to fight AIDS, business group says - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
